SANUWAVE Health, Inc.
SNWV
$15.14
$0.231.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.06% | 26.81% | 22.34% | 41.92% | 61.30% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.06% | 26.81% | 22.34% | 41.92% | 61.30% |
| Cost of Revenue | 11.75% | 48.45% | 10.16% | 14.78% | 23.61% |
| Gross Profit | 0.76% | 20.66% | 26.29% | 51.87% | 75.51% |
| SG&A Expenses | 20.00% | 24.91% | 45.17% | 98.85% | 29.90% |
| Depreciation & Amortization | 28.13% | 32.13% | 7.77% | -3.33% | 5.49% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.03% | 36.18% | 34.79% | 60.29% | 27.74% |
| Operating Income | -287.02% | -19.51% | -24.88% | -5.77% | 157.24% |
| Income Before Tax | 76.48% | 142.93% | 149.98% | -83.92% | -35.11% |
| Income Tax Expenses | -- | 218.52% | -- | -- | -- |
| Earnings from Continuing Operations | 76.48% | 142.25% | 149.98% | -83.92% | -35.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 76.48% | 142.25% | 149.98% | -83.92% | -35.11% |
| EBIT | -287.02% | -19.51% | -24.88% | -5.77% | 157.24% |
| EBITDA | -202.47% | -11.10% | -19.58% | -8.58% | 188.62% |
| EPS Basic | 76.60% | 141.46% | 118.58% | -94.08% | 51.01% |
| Normalized Basic EPS | 76.59% | 139.66% | 110.79% | -68.95% | 49.85% |
| EPS Diluted | 76.60% | 101.25% | 107.13% | -99.60% | 51.01% |
| Normalized Diluted EPS | 76.59% | 138.66% | 110.12% | -65.97% | 49.85% |
| Average Basic Shares Outstanding | 0.51% | 1.90% | 169.07% | 171.58% | 175.79% |
| Average Diluted Shares Outstanding | 0.51% | 4.54% | 186.95% | 147.81% | 175.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |